ZEB2 and hepatocellular carcinoma: The results showed that the ZEB2 antibody used in this study recognized only one band by Western blotting, and down-regulated expression of ZEB2 was detected in 9/12 (75.0%) cases of primary HCC tissues compared to adjacent non-neoplastic liver tissues (Figure S1).